Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Evaluation of a visual read method for flortaucipir PET Scans

Anupa Arora, Michael Pontecorvo, Mark Mintun, Adam Fleisher, Michael Devous, Ming Lu, Nicholas Galante, Patricia Stevenson, Matthew Flitter and Stephen Truocchio
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 252;
Anupa Arora
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Pontecorvo
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Mintun
2Avid Radiopharmaceuticals, Inc. Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Fleisher
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Devous
2Avid Radiopharmaceuticals, Inc. Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming Lu
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Galante
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Stevenson
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Flitter
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Truocchio
1Avid Radiopharmaceuticals Philadelphia PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

252

Objectives: To evaluate a clinically applicable visual read method for flortaucipir PET scans.

Methods: Five imaging physicians were trained in-person using a predefined read methodology to visually interpret flortaucipir PET scans. After scaling images to cerebellum, they were instructed to evaluate regions of the neocortex (the posterolateral temporal (PLT), occipital, parietal and frontal regions) for increased tracer uptake, and interpret scans as either not consistent (tAD-) or consistent with an AD pattern (tAD+ or tAD++) using the following criteria: tAD-: no increased activity or increased activity isolated to the mesial temporal, anterior lateral temporal, and/or frontal region(s) tAD+: increased activity in the PLT or occipital region(s) tAD++: increased activity in the parietal/precuneus region(s) or frontal region with PLT, occipital, or parietal region(s) Read categories were derived from longitudinal studies, where increased neocortical uptake in the PLT was associated with amyloid positivity, and activity beyond the PLT/occipital regions was associated with greater cognitive decline. After training on demonstration and practice cases, all readers independently read 105 scans from end-of-life subjects enrolled in a Phase 3 clinico-pathological trial (study A16) plus 17 scans from a supplemental academic cohort (total n=122). The primary analyses tested sensitivity and specificity for a flortaucipir PET scan visual interpretation consistent with AD (tAD+/tAD++) to detect AD tau pathology (Braak V/VI) and high level of AD neuropathologic change in patients who came to autopsy (n=82).

Results: 82 cases came to autopsy and had evaluable scans. Median sensitivity and specificity for a flortaucipir PET AD pattern to identify Braak V/VI pathology were 89.1% and 83.3%, respectively. The median sensitivity and specificity for identifying high AD neuropathic change (NIA-AA path criteria) were 95.1% and 80.5%, respectively. Interrater reliability as measured by Fleiss’ kappa for all interpreted scans (n=122) was 0.80 and overall agreement was 90.3%. Results from additional studies will also be presented.

Conclusions: There was substantial agreement among readers. Using the read method, readers were able to identify scans associated with AD pathology at autopsy.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of a visual read method for flortaucipir PET Scans
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of a visual read method for flortaucipir PET Scans
Anupa Arora, Michael Pontecorvo, Mark Mintun, Adam Fleisher, Michael Devous, Ming Lu, Nicholas Galante, Patricia Stevenson, Matthew Flitter, Stephen Truocchio
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 252;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of a visual read method for flortaucipir PET Scans
Anupa Arora, Michael Pontecorvo, Mark Mintun, Adam Fleisher, Michael Devous, Ming Lu, Nicholas Galante, Patricia Stevenson, Matthew Flitter, Stephen Truocchio
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 252;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET quantifies target engagement of MAGL therapeutics for Alzheimer’s disease
  • Multiparametric magnetic resonance imaging and positron emission tomography findings in the diagnosis of primary progressive aphasia – A case based approach and review of literature
  • Role of 18F-FDG PET scan in diagnosis of autoimmune encephalitis
Show more Neurosciences

Amyloid and Tau PET

  • Amyloid Load in the Down syndrome population measured with [11C]PiB PET
  • Sex Modulates the ApoE ε4 Effect on Tau 18F-AV-1451 PET Imaging in Individuals with Normal Aging and Mild Cognitive Impairment
Show more Amyloid and Tau PET

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire